Recent advancements in loco-regional therapy are revolutionizing the point-of-care (POC) drug delivery field, enhancing the convenience, comfort, and effectiveness of these devices for patients. New anticancer drugs have improved the therapy, but there is still significant work to be done in order to selectively target tumour cells. To bridge this gap, here, we present a minimally invasive tool based on optical fibers (OFs) integrated in a microfluidic device for light-triggered loco regional delivery of drug-loaded particles. Specifically, we, here, selected the Lab on Fiber (LOF) technology as an attractive option to guide light and trigger the drug release. LOF, indeed, enables precise drug dosing and targeted transport, laying the foundation for mini-invasive platforms in light-activated loco-regional drug delivery. The platform includes drug-loaded carriers covalently attached on the OF surface through a photocleavable linker. The OF platform has been designed to spread light from the core region towards the cladding area in order to achieve enough power density to photo-cleave the linker and release the carrier. To this aim, side-emitting and core-offset OFs optrodes have been designed, fabricated and characterized achieving power density and scattering efficiency of 30% and 5mW/cm2 and 24.9% and 4.64mW/cm2. OFs were integrated into a microfluidic device and the particle release upon light activation was quantified. The side-emitting OF microfluidic system, designed for Hepatocellular cancer therapy, released 2.60μg/ml of carriers, while the core-offset OF microfluidic system, for Breast cancer treatment, released 1.06μg/ml of carriers. This approach holds potential for improving cancer treatment outcomes
Lab-on-Fiber (LoF) technology is a research field aimed at transforming a simple optical fiber into a multifunctional probe, which exploits enhanced light-matter interaction for a variety of applications, with special aptitude for biosensing. An attractive thread in this scenario is the integration of plasmonic metasurfaces onto an optical fiber tip, known as optical fiber “meta-tips”, leading to the development of a new generation of highly sensitive optrodes. Here we report on the latest achievements concerning the investigation of LoF probes assisted by plasmonic phase-gradient metasurfaces for the detection of small molecules as well as clinically relevant cancer biomarkers in the picomolar range. The high biosensing performance, joined with huge potential for miniaturization and integration, makes this platform an excellent candidate for the development of Point-of-Care (PoC) devices aimed at real-time and label-free detection of clinically relevant biomarkers offering several advantages over conventional procedures.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.